Vitamin D deficiency in patients with inflammatory bowel disease: Association with disease activity and quality of life

Journal of Parenteral and Enteral Nutrition

Volumn 35, Issue 3, 2011, Pages 308-316

  Ulitsky, Alex ^a   Ananthakrishnan, Ashwin N ^a   Naik, Amar ^a   Skaros, Sue ^a   Zadvornova, Yelena ^a   Binion, David G ^b   Issa, Mazen ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's disease; Harvey Bradshaw index; inflammatory bowel disease; quality of life; Short IBD Questionnaire; ulcerative colitis; vitamin D

Indexed keywords

VITAMIN D;

ADULT; ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HARVEY BRADSHAW INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SCORING SYSTEM; SHORT INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADULT; AGE FACTORS; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PREVALENCE; QUALITY OF LIFE; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAMIN D DEFICIENCY;

EID: 79955653072     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607110381267     Document Type: Article

References (54)

1. Siffledeen JS, Siminoski K, Steinhart H, Greenberg G, Fedorak RN. The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol. 2003 ; 17: 473-478 (Pubitemid 37321992)
2. McCarthy D, Duggan P, O'Brien M, et al. Seasonality of vitamin D status and bone turnover in patients with Crohn's disease. Aliment Pharmacol Ther. 2005 ; 21: 1073-1083 (Pubitemid 40646532)
3. Tajika M, Matsuura A, Nakamura T, et al. Risk factors for vitamin D deficiency in patients with Crohn's disease. J Gastroenterol. 2004 ; 39: 527-533 (Pubitemid 38996894)
4. Mezquita Raya P, Munoz Torres M, et al. Prevalence of vitamin D deficiency in populations at risk for osteoporosis: Impact on bone integrity. Med Clin (Barc). 2002 ; 119: 85-89 (Pubitemid 34874046)
5. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol. 2002 ; 37: 192-199 (Pubitemid 34102257)
6. Andreassen H, Rix M, Brot C, Eskildsen P. Regulators of calcium homeostasis and bone mineral density in patients with Crohn's disease. Scand J Gastroenterol. 1998 ; 33: 1087-1093 (Pubitemid 28505654)
7. Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol. 1995 ; 7: 609-614
8. Bischoff SC, Herrmann A, Goke M, Manns MP, von zur Muhlen A, Brabant G. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol. 1997 ; 92: 1157-1163 (Pubitemid 27304813)
9. Harries AD, Brown R, Heatley RV, Williams LA, Woodhead S, Rhodes J. Vitamin D status in Crohn's disease: association with nutrition and disease activity. Gut. 1985 ; 26: 1197-1203 (Pubitemid 16216265)
10. Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology. 1982 ; 83: 1252-1258 (Pubitemid 13235925)
11. Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med. 1996 ; 239: 131-137 (Pubitemid 26043148)
12. Cantorna MT, Munsick C, Bemiss C, Mahon BD. 1,25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr. 2000 ; 130: 2648-2652
13. Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, Cantorna MT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol. 2003 ; 17: 2386-2392 (Pubitemid 37542204)
14. Gilman J, Shanahan F, Cashman KD. Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use. Eur J Clin Nutr. 2006 ; 60: 889-896 (Pubitemid 43997702)
15. Headstrom PD, Rulyak SJ, Lee SD. Prevalence of and risk factors for vitamin B(12) deficiency in patients with Crohn's disease. Inflamm Bowel Dis. 2008 ; 14: 217-223 (Pubitemid 351288043)
16. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006 ; 55: 749-753 (Pubitemid 43764536)
17. Ananthakrishnan AN, Weber LR, Knox JF, et al. Permanent work disability in Crohn's disease. Am J Gastroenterol. 2008 ; 103: 154-161
18. Sutherland LR, Martin F, Greer S, et al. 5-aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987 ; 92: 1894-1898 (Pubitemid 17072238)
19. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980 ; 1: 514
20. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial. Am J Gastroenterol. 1996 ; 91: 1571-1578 (Pubitemid 26269173)
21. Shinchuk LM, Holick MF. Vitamin D and rehabilitation: improving functional outcomes. Nutr Clin Pract. 2007 ; 22: 297-304
22. Dawson-Hughes B, Heaney RP, et al. Estimates of optimal vitamin D status. Osteoporos Int. 2005 ; 16: 713-716 (Pubitemid 40933586)
23. Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr. 2003 ; 22: 142-146 (Pubitemid 36417827)
24. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006 ; 84: 18-28 (Pubitemid 44699167)
25. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet. 1998 ; 351: 805-806 (Pubitemid 28112350)
26. Thomas MK, Lloyd-Jones DM, Thadhani RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med. 1998 ; 338: 777-783 (Pubitemid 28135983)
27. Lamb EJ, Wong T, Smith DJ, et al. Metabolic bone disease is present at diagnosis in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2002 ; 16: 1895-1902 (Pubitemid 35253005)
28. Lee SH, Kim HJ, Yang SK, et al. Decreased trabecular bone mineral density in newly diagnosed inflammatory bowel disease patients in Korea. J Gastroenterol Hepatol. 2000 ; 15: 512-518
29. Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbrugger RW, Brummer RJ. Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology. 2000 ; 119: 1203-1208
30. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004 ; 80 (6 suppl). 1717S - 1720S
31. Ponsonby AL, McMichael A, van der Mei I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology. 2002 ; 181-182: 71-78 (Pubitemid 36015675)
32. Van Amerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr. 2004 ; 58: 1095-1109 (Pubitemid 39172383)
33. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 ; 296: 2832-2838 (Pubitemid 44969183)
34. Haussler MR, Whitfield GK, Haussler CA, et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res. 1998 ; 13: 325-349 (Pubitemid 28146215)
35. Sutton AL, MacDonald PN. Vitamin D: More than a "bone-a-fide" hormone. Mol Endocrinol. 2003 ; 17: 777-791 (Pubitemid 36539572)
36. Kuhn R, Rajewsky K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science. 1991 ; 254: 707-710 (Pubitemid 21917392)
37. Cantorna MT, Mahon BD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood). 2004 ; 229: 1136-1142 (Pubitemid 39602256)
38. Zhu Y, Mahon BD, Froicu M, Cantorna MT. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol. 2005 ; 35: 217-224 (Pubitemid 40123868)
39. Kong J, Zhang Z, Musch MW, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol. 2008 ; 294: G208 - G216
40. Lo CW, Paris PW, Clemens TL, Nolan J, Holick MF. Vitamin D absorption in healthy subjects and in patients with intestinal malabsorption syndromes. Am J Clin Nutr. 1985 ; 42: 644-649 (Pubitemid 15245058)
41. Vogelsang H, Schofl R, Tillinger W, Ferenci P, Gangl A. 25-hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency. Wien Klin Wochenschr. 1997 ; 109: 678-682 (Pubitemid 27420177)
42. Pappa HM, Grand RJ, Gordon CM. Report on the vitamin D status of adult and pediatric patients with inflammatory bowel disease and its significance for bone health and disease. Inflamm Bowel Dis. 2006 ; 12: 1162-1174 (Pubitemid 44847474)
43. Vogelsang H, Klamert M, Resch H, Ferenci P. Dietary vitamin D intake in patients with Crohn's disease. Wien Klin Wochenschr. 1995 ; 107: 578-581
44. Sentongo TA, Semaeo EJ, Stettler N, Piccoli DA, Stallings VA, Zemel BS. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr. 2002 ; 76: 1077-1081 (Pubitemid 35244680)
45. Jowett SL, Seal CJ, Phillips E, Gregory W, Barton JR, Welfare MR. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Clin Nutr. 2004 ; 23: 161-170 (Pubitemid 38401210)
46. Holick MF, Shao Q, Liu WW, Chen TC. The vitamin D content of fortified milk and infant formula. N Engl J Med. 1992 ; 326: 1178-1181
47. Leichtmann GA, Bengoa JM, Bolt MJ, Sitrin MD. Intestinal absorption of cholecalciferol and 25-hydroxycholecalciferol in patients with both Crohn's disease and intestinal resection. Am J Clin Nutr. 1991 ; 54: 548-552 (Pubitemid 21898967)
48. Clements MR, Chalmers TM, Fraser DR. Enterohepatic circulation of vitamin D: a reappraisal of the hypothesis. Lancet. 1984 ; 1: 1376-1379 (Pubitemid 14122019)
49. Karbach U, Ewe K. Enteric protein loss in various gastrointestinal diseases determined by intestinal alpha 1-antitrypsin clearance. Z Gastroenterol. 1989 ; 27: 362-365 (Pubitemid 19215723)
50. Saitoh O, Matsumoto H, Sugimori K, et al. Intestinal protein loss and bleeding assessed by fecal hemoglobin, transferrin, albumin, and alpha-1-antitrypsin levels in patients with colorectal diseases. Digestion. 1995 ; 56: 67-75
51. Moum B, Aadland E, Ekbom A, Vatn MH. Seasonal variations in the onset of ulcerative colitis. Gut. 1996 ; 38: 376-378 (Pubitemid 26074317)
52. Sellu DP. Seasonal variation in onset of exacerbations of ulcerative proctocolitis. J R Coll Surg Edinb. 1986 ; 31: 158-160 (Pubitemid 16009871)
53. Vogelsang H, Ferenci P, Woloszczuk W, et al. Bone disease in vitamin D-deficient patients with Crohn's disease. Dig Dis Sci. 1989 ; 34: 1094-1099 (Pubitemid 19188893)
54. Matsuoka LY, Wortsman J, Hollis BW. Use of topical sunscreen for the evaluation of regional synthesis of vitamin D3. J Am Acad Dermatol. 1990 ; 22: 772-775 (Pubitemid 20154075)